Biotech

red and purple piggy banks
Biotech

Syncona cites 'challenging' market for switching investment plan

Life sciences firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs.
James Waldron Jun 20, 2025 6:00am
Life buoy and American Dollar sign

4 strange cash-saving efforts biotechs are using to stay afloat

Jun 20, 2025 6:00am
Precision medicines next frontier unlocking the power of biospecimens

Unlocking the power of biospecimens

Jun 16, 2025 8:00am
A series of dice with a bag on them illustrating cost cuts

Prothena lays off 63% in fallout from phase 3 amyloidosis fail

Jun 20, 2025 2:23am
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
Reorganization team change restructure

Industry disappointed as FDA puts gene therapy chief on leave

Jun 20, 2025 1:53am